Bristol Myers' Opdivo with Exelixis drug cuts kidney cancer death risk: study

By Michael Erman

The requested article has expired, and is no longer available. Any related articles, and user comments are shown below.

© Thomson Reuters 2020.

©2021 GPlusMedia Inc.

Login to comment

If we were watching an ad for this drug in America (and ads for prescription drugs are played on tv every 5 minutes) it would probably say “Side effects may include dry mouth, dizziness, loss of balance, erectile dysfunction, heart palpitations, suicidal or homicidal ideation, hair loss, ringing of the ears, and in rare cases, sudden death.”

0 ( +0 / -0 )

Dubious company, dubious drug. Bristol deserves special attention due to a lack of internal oversights and loose compliance with rules and regulations fo the countries in which they operate.

0 ( +0 / -0 )

Login to leave a comment

Facebook users

Use your Facebook account to login or register with JapanToday. By doing so, you will also receive an email inviting you to receive our news alerts.

Facebook Connect

Login with your JapanToday account

User registration

Articles, Offers & Useful Resources

A mix of what's trending on our other sites